A groundbreaking materials — engineered bone marrow (eBM) — has the potential to enhance therapy for osteosarcoma, a malignant bone most cancers with...
Newswise — In 2022, Alaggio and colleagues revised the WHO Classification of Haematolymphoid Tumors leading to elimination of the provisional diagnostic classes of...
